ACE2 and breast carcinoma: Recently, a study revealed lower ACE2 expression in breast cancer cells compared to normal tissues, and the low ACE2 level contributed to the deterioration of prognosis, indicating that ACE2 may act as a beneficial effect on breast cancer [23], which is consistent with the conclusion of our study.